A modified 384-well-device for versatile use in 3D cancer cell (co-)cultivation and screening for investigations of tumor biology in vitro
- PMID: 29610566
- PMCID: PMC5873453
- DOI: 10.1002/elsc.201700008
A modified 384-well-device for versatile use in 3D cancer cell (co-)cultivation and screening for investigations of tumor biology in vitro
Abstract
Pancreatic cancer exhibits a worst prognosis owed to an aggressive tumor progression i.a. driven by chemoresistance or tumor-stroma-interactions. The identification of candidate genes, which promote this progression, can lead to new therapeutic _targets and might improve patient's outcome. The identification of these candidates in a plethora of genes requires suitable screening protocols. The aim of the present study was to establish a universally usable device which ensures versatile cultivation, screening and handling protocols of cancer cells with the 3D spheroid model, an approved model to study tumor biology. By surface modification and alternative handling of a commercial 384-well plate, a modified device enabling (i) 3D cultivation either by liquid overlay or by a modified hanging drop method for (ii) screening of substances as well as for tumor-stroma-interactions (iii) either with manual or automated handling was established. The here presented preliminary results of cell line dependent dose-response-relations and a stromal-induced spheroid-formation of the pancreatic cancer cells demonstrate the proof-of-principle of the versatile functionality of this device. By adapting the protocols to automation, a higher reproducibility and the ability for high-throughput analyses were ensured.
Keywords: 3D cell culture; Automation; Pancreatic cancer; Substance screening; Tumor‐stroma‐interaction.
Figures
Similar articles
-
Generation of an in vitro 3D PDAC stroma rich spheroid model.Biomaterials. 2016 Nov;108:129-42. doi: 10.1016/j.biomaterials.2016.08.041. Epub 2016 Sep 2. Biomaterials. 2016. PMID: 27627810 Free PMC article.
-
Digital microfluidics for automated hanging drop cell spheroid culture.J Lab Autom. 2015 Jun;20(3):283-95. doi: 10.1177/2211068214562002. Epub 2014 Dec 15. J Lab Autom. 2015. PMID: 25510471
-
Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.J Exp Clin Cancer Res. 2018 Jan 12;37(1):4. doi: 10.1186/s13046-017-0654-6. J Exp Clin Cancer Res. 2018. PMID: 29329547 Free PMC article.
-
First steps towards the successful surface-based cultivation of human embryonic stem cells in hanging drop systems.Eng Life Sci. 2012 Nov;12(6):584-587. doi: 10.1002/elsc.201100213. Epub 2012 Aug 1. Eng Life Sci. 2012. PMID: 23486530 Free PMC article.
-
Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.J Cancer Res Clin Oncol. 2017 Sep;143(9):1771-1786. doi: 10.1007/s00432-017-2434-2. Epub 2017 May 11. J Cancer Res Clin Oncol. 2017. PMID: 28497169
Cited by
-
A novel anti Candida albicans drug screening system based on high-throughput microfluidic chips.Sci Rep. 2019 May 30;9(1):8087. doi: 10.1038/s41598-019-44298-w. Sci Rep. 2019. PMID: 31147583 Free PMC article.
-
Flexible Toolbox of High-Precision Microfluidic Modules for Versatile Droplet-Based Applications.Micromachines (Basel). 2024 Feb 7;15(2):250. doi: 10.3390/mi15020250. Micromachines (Basel). 2024. PMID: 38398978 Free PMC article.
-
Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine.Cells. 2023 Mar 24;12(7):1001. doi: 10.3390/cells12071001. Cells. 2023. PMID: 37048073 Free PMC article. Review.
-
Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening.Artif Organs. 2021 Jun;45(6):548-558. doi: 10.1111/aor.13880. Epub 2021 Jan 10. Artif Organs. 2021. PMID: 33264436 Free PMC article. Review.
References
-
- Siegel, R. L. , Miller, K. D. , Jemal, A. , Cancer statistics, 2016. CA Cancer J. Clin. 2016, 66, 7–30. - PubMed
-
- Kelsen, D. P. , Portenoy, R. , Thaler, H. , Tao, Y. et al., Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery 1997, 122, 53–59. - PubMed
-
- Gottesman, M. M. , Mechanisms of cancer drug resistance. Annu. Rev. Med. 2002, 53, 615–627. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources